Hidden Communication Identity of Drug Abusers Among Early Adolescent
Lintang Nur Hemas, Prahastiwi Utari, Mahendra Wijaya
Lintang Nur Hemas
Available Online 25 March 2020.
- https://doi.org/10.2991/assehr.k.200323.021How to use a DOI?
- identity, CTI, communication theory of identity, drug abusers, early adolescent
- This study aims to examine the hidden identity of early adolescent drug users using Communication Theory of Identity. This research is qualitative which case study as research method. The interview were conducted with three drug abusers in one of junior high school in Kendal District. The results showed that communication identity at the personal layer, drug abusers have a negative self-image by family and school friends and a positive self-image by fellow abusers. At the enacted layer the identity enforced through communication through a number of special terms among drug abusers. Relational layer showed more intimate and comfortable relationship with fellow drug abusers than with other parties, although other facts showed there were no difference in the relationship between both of them. Communal layer showed the strong influence of drug abusers group on the decision to abuse drugs, there were different sensations when abusing drugs in groups, and had the desire to stay away from the group in order to stop abusing even it was difficult. In conclusion, drug abusers as communication identities, possible to concealed and disclosed with negative and positive consequence based on the experience of communicating individuals with others.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Cite this article
TY - CONF AU - Lintang Nur Hemas AU - Prahastiwi Utari AU - Mahendra Wijaya PY - 2020 DA - 2020/03/25 TI - Hidden Communication Identity of Drug Abusers Among Early Adolescent BT - 4th International Conference on Arts Language and Culture (ICALC 2019) PB - Atlantis Press SP - 172 EP - 185 UR - https://doi.org/10.2991/assehr.k.200323.021 DO - https://doi.org/10.2991/assehr.k.200323.021 ID - Hemas2020 ER -